检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

ENGOT-en11/GOG-3053/KEYNOTE-B21: A phase 3 study of pembrolizumab or placebo in combination with adjuvant chemotherapy with or without radiotherapy in patients with newly diagnosed high-risk endometrial cancer (570)

Brian Slomovitz,Mansoor Mirza,Alain Lortholary,Ignace Vergote,David Cibula,Axel Walther,Antonella Savarese,Maria Pilar Barretina Ginesta,Firat Ortac,Christos Papadimitriou,Lubomir Bodnar,Chyong-Huey Lai,Kosei Hasegawa,Xiaojun Chen,Emma Barber,Robert Coleman,Stephen Keefe,Robert Orlowski,Toon Van Gorp

Gynecologic Oncology（2022）

引用 3|浏览9
暂无评分
关键词
endometrial cancer,pembrolizumab,adjuvant chemotherapy,radiotherapy,high-risk
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要